Predictors of lung adenocarcinoma with leptomeningeal metastases: a 2022 targeted-therapy-assisted molgpa model

HIGHLIGHTS

• who: Milan Zhang from the Germany Medical University of Vienna, Austria have published the paper: Predictors of Lung Adenocarcinoma With Leptomeningeal Metastases: A 2022 Targeted-Therapy-Assisted molGPA Model, in the Journal: (JOURNAL)
• what: The authors compared the effects of gene mutation status and targeted therapy on survival, and developed a novel 2022 lung-molGPA for the patients of lung adenocarcinoma with LM. Third, this study evaluated only lung cancer, not other solid cancers, such as melanoma and breast cancer, which are also common in LM.
• how: The results showed that the p . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.